1. Home
  2. XBIT vs ANPA Comparison

XBIT vs ANPA Comparison

Compare XBIT & ANPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.36

Market Cap

74.4M

Sector

Health Care

ML Signal

HOLD

Logo Rich Sparkle Holdings Limited Ordinary Shares

ANPA

Rich Sparkle Holdings Limited Ordinary Shares

N/A

Current Price

$4.20

Market Cap

69.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
ANPA
Founded
2005
2016
Country
United States
Hong Kong
Employees
N/A
32
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.4M
69.5M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
XBIT
ANPA
Price
$2.36
$4.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
29.4K
5.4K
Earning Date
05-08-2026
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$2.80
52 Week High
$3.61
$180.64

Technical Indicators

Market Signals
Indicator
XBIT
ANPA
Relative Strength Index (RSI) 46.97 31.26
Support Level $2.26 $3.91
Resistance Level $2.49 $6.46
Average True Range (ATR) 0.05 0.41
MACD 0.01 0.05
Stochastic Oscillator 29.59 36.11

Price Performance

Historical Comparison
XBIT
ANPA

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About ANPA Rich Sparkle Holdings Limited Ordinary Shares

Rich Sparkle Holdings Ltd is a holding company conducting its operations as a professional specialist in the provision of financial printing services such as printing, typesetting and translation, advisory services including Environmental, Social and Governance (ESG) and internal control reporting services and other services including standalone annual general meeting and extraordinary general meeting supporting service and other standalone services, through its sole operating subsidiary in Hong Kong. Its segments include Financial printing services such as printing, typesetting and translation, Advisory services including Environmental, Social and Governance Report and Other services.

Share on Social Networks: